OR WAIT null SECS
November 02, 2016
A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.
October 05, 2016
Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for direct compression.
The OptiForm Solution Suite platform offers easy, simple, fast, and cost-effective approaches for both small and macromolecules in early development phases.
October 02, 2016
This article will equip the excipient vendor with an understanding of QbD from the perspective of the topical pharmaceutical product manufacturer.
Excipients play a crucial role in the manufacturing of solid-dosage forms and the performance of the finished drug product.
Understanding the components of a reference marketed pMDI is needed to develop a generic pMDI.
September 02, 2016
Nanoparticulate technologies are showing promising potential in delivering both small-molecule drugs and biomacromolecules across the blood brain barrier.
September 01, 2016
One of the major challenges in working with excipients today is understanding, and adjusting to, complexity in materials and formulations.
IPEC consultant Irwin Silverstein discusses third-party audits and regulatory compliance issues facing suppliers and their customers.
Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.